Autres langues DexCom, Inc.

Actions

DXCM

US2521311074

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 09/09/2026			Varia. 5j.	Varia. 1 janv.
83,88 ^USD	-0,77 %		-6,94 %	+26,38 %

09/09	Transcript : DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM
24/08	Dexcom : un dirigeant cède des actions pour un montant de 2 408 242 $, selon un document de la SEC	MT

Autres langues

01/09	Dexcom Announces Upcoming Conference Presentation
24/08	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing
31/07	DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says
31/07	Afternoon meeting: Wall Street vuelve a comprar en las caídas
31/07	Wall Street's Dip Buyers Return
31/07	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
30/07	Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on May 15, 2026.
30/07	DexCom, Inc. Raises Earnings Guidance for the Fiscal Year 2026
30/07	DexCom Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance
30/07	Dexcom raises annual revenue forecast on strong demand for glucose monitors
30/07	(DXCM) DexCom Expects Full Year 2026 Revenue Range $5.18B - $5.25B, vs. FactSet Est of $5.22B
30/07	DexCom: Q2 Earnings Snapshot
30/07	Earnings Flash (DXCM) DexCom, Inc. Reports Q2 Revenue $1.31B, vs. FactSet Est of $1.29B
30/07	Earnings Flash (DXCM) DexCom, Inc. Posts Q2 Adjusted EPS $0.70 per Share, vs. FactSet Est of $0.61
30/07	Dexcom Reports Second Quarter 2026 Financial Results
30/07	DexCom, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Align Technology to add directors, launch review after deal with Elliott
29/07	Alert from law firm on Dexcom withdrawn
22/07	Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program
21/07	Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing
17/07	Compañías que se deben tener muy en cuenta por técnico este viernes en Wall Street
17/07	Valores destacados al cierre del mercado norteamericano
16/07	Abbott raises 2026 profit forecast on heart device strength
13/07	DexCom's G7 Glucose Monitor Receives Health Canada Authorization for Adults With Diabetes